The clinical impact of metabolic bone disease in coeliac disease

Bone mineral density was measured by dual energyx ray absorptiometry (DEXA) at the lumbar spine and femoral neck in 15 adults who had metabolic bone disease in association with coeliac disease (mean age at diagnosis 53.5 years, range 37 to 66). Results were expressed as a T score (the number of stan...

Full description

Saved in:
Bibliographic Details
Published inPostgraduate medical journal Vol. 77; no. 903; pp. 33 - 36
Main Authors Fickling, W E, McFarlane, X A, Bhalla, A K, Robertson, D A F
Format Journal Article
LanguageEnglish
Published London The Fellowship of Postgraduate Medicine 01.01.2001
BMJ
BMJ Publishing Group Ltd
Oxford University Press
BMJ Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bone mineral density was measured by dual energyx ray absorptiometry (DEXA) at the lumbar spine and femoral neck in 15 adults who had metabolic bone disease in association with coeliac disease (mean age at diagnosis 53.5 years, range 37 to 66). Results were expressed as a T score (the number of standard deviations by which patient's bone density differed from the sex matched young adult mean). Three patients had no skeletal symptoms and normal routine calcium biochemistry but severely reduced axial bone mineral density on DEXA. Eleven patients had symptomatic skeletal fractures, including fractures of proximal femur (3), vertebrae (4), and radius (6). Three patients had osteomalacia confirmed on bone biopsy, two of whom had characteristic biochemistry. Secondary and tertiary hyperparathyroidism were seen. Seventy five further patients (60 female) with coeliac disease (mean age 52.0 years, median duration of gluten-free diet 3.4 years) and 75 paired healthy age and sex matched controls were questioned on past fracture history. Patients with coeliac disease underwent detailed studies of calcium biochemistry, dietary intake, and bone mineral density. Sixteen had a past history of fractures (χ2 = 10.7, p = 0.0004,v controls), which were of typical osteoporotic type. Ten patients had fracture before diagnosis of coeliac disease and six after diagnosis. Patients who had a fracture were older (56.3 v 50.3 years, p < 0.02, Wilcoxon rank sum test) than those with no fracture. There was no significant difference in bone mineral density (z score −0.31v −0.77), serum calcium (2.30v 2.26 mmol/l), 25-hydroxyvitamin D (19.7v 23.7 nmol/l), parathyroid hormone (2.6v 3.1 pmol/l), or dietary calcium intake (1021.0 v 1033.0 mg/day) in patients with fracture compared with those without fracture. Metabolic bone disease is common in coeliac disease and is associated with premature osteoporotic fractures.
Bibliography:href:postgradmedj-77-33.pdf
ark:/67375/NVC-TLSP00RQ-N
istex:99E7BEB5ACA499EFD35EDBDF9884B89594AAA5AB
PMID:11123392
local:postgradmedj;77/903/33
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0032-5473
1469-0756
DOI:10.1136/pmj.77.903.33